Skip to main content

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued FOA Number Activity Code Posting Date Expiration Date Opportunity Type
Notice of Clarification to PAR-21-293 "Clinical and Translational Science Award (UM1 Clinical Trial Optional)" NOT-TR-24-029 06/26/2024 Notice of Change to Funding Opportunity
Notice of Intent to Re-issue PAR-22-167 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) NOT-TR-24-028 06/24/2024 Notice of Intent to Publish
Notice of Information: Technical Assistance Webinars for PAR-24-206: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) NOT-TR-24-024 05/01/2024 Notice of Information
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) PAR-24-131 R43/R44 04/25/2024 11/16/2025 NA
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) PAR-24-133 R41/R42 04/25/2024 11/16/2025 NA
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) PAR-24-197 R03 04/17/2024 12/10/2024 NA
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) PAR-24-197 R03 04/17/2024 07/16/2026 NA
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) PAR-24-206 U54 04/02/2024 08/13/2024 NA
Termination of NOSI NOT-OD-22-191 - Administrative Supplements to NCATS CTSA Program T32/TL1 Institutional Training Program as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project NOT-TR-24-016 04/03/2024 Notice of Change to Funding Opportunity
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) RFA-TR-24-023 R21 04/03/2024 06/02/2026 NA
Showing Row 51 to 60 of 419

Last updated on February 19, 2025